New Once Daily Alzheimer’s Capsule Hits MarketSENIOR JOURNAL.COM - Senior Citizens Information and NewsMay 24, 2005 – There is a new once-a-day capsule for Alzheimer’s Disease patients but the identification may be confusing. Razadyne ER is the new formula for mild to moderate Alzheimer’s treatment. Razadyne, however, was known as Reminyl until last month, when the name was changed.In clinical trials, the most frequent adverse events with Razadyne ER were similar to those seen with Razadyne. The most common side effects are nausea, vomiting, diarrhea, loss of appetite, and weight loss. Typically, these side effects are mild and temporary. Razadyne may not be for everyone. Some people experience a slowed heart rate, which may lead to fainting. Serious stomach problems can occur in people taking medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or those at risk for stomach ulcers. Please see www.Razadyne.com for full prescribing information or call 1-800-526-7736 for more information.
RAZADYNE COM
reminyl used to treat
